Literature DB >> 17954685

No genetic bottleneck in Plasmodium falciparum wild-type Pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance.

Nanhua Chen1, Qi Gao, Shanqing Wang, Guangze Wang, Michelle Gatton, Qin Cheng.   

Abstract

Chloroquine-resistant Plasmodium falciparum was highly prevalent in Hainan, China, in the 1970s. Twenty-five years after cessation of chloroquine therapy, the prevalence of P. falciparum wild-type Pfcrt alleles has risen to 36% (95% confidence interval, 22.1 to 52.4%). The diverse origins of wild-type alleles indicate that there was no genetic bottleneck caused by high chloroquine resistance.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17954685      PMCID： PMC2223894          DOI： 10.1128/AAC.00711-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines.

Authors:  Nanhua Chen; Dennis E Kyle; Cielo Pasay; Elizabeth V Fowler; Joanne Baker; Jennifer M Peters; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines.

Authors:  Nanhua Chen; Danny W Wilson; Cielo Pasay; David Bell; Laura B Martin; Dennis Kyle; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China.

Authors:  Xinhua Wang; Jianbing Mu; Guoqiao Li; Peiquan Chen; Xingbo Guo; Linchun Fu; Lin Chen; Xinzhuan Su; Thomas E Wellems
Journal:  Am J Trop Med Hyg       Date:  2005-04       Impact factor: 2.345

Review 5.  Chloroquine-resistant malaria.

Authors:  T E Wellems; C V Plowe
Journal:  J Infect Dis       Date:  2001-08-07       Impact factor: 5.226

6.  Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon.

Authors:  L C Ranford-Cartwright; J Taylor; T Umasunthar; L H Taylor; H A Babiker; B Lell; J R Schmidt-Ott; L G Lehman; D Walliker; P G Kremsner
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

7.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.

Authors:  John C Wootton; Xiaorong Feng; Michael T Ferdig; Roland A Cooper; Jianbing Mu; Dror I Baruch; Alan J Magill; Xin-Zhuan Su
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

8.  Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China.

Authors:  D Q Liu; R J Liu; D X Ren; D Q Gao; C Y Zhang; C P Qui; X Z Cai; C F Ling; A H Song; X Tang
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

9.  Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.

Authors:  James G Kublin; Joseph F Cortese; Eric Mbindo Njunju; Rabia A G Mukadam; Jack J Wirima; Peter N Kazembe; Abdoulaye A Djimdé; Bourema Kouriba; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2003-05-21       Impact factor: 5.226

10.  In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.

Authors:  Leonardo K Basco; Pascal Ringwald
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191
  10 in total
  10 in total

1.  Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.

Authors:  Mónica Guerra; Rita Neres; Patrícia Salgueiro; Cristina Mendes; Nicolas Ndong-Mabale; Pedro Berzosa; Bruno de Sousa; Ana Paula Arez
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

2.  Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter.

Authors:  Ines Petersen; Stanislaw J Gabryszewski; Geoffrey L Johnston; Satish K Dhingra; Andrea Ecker; Rebecca E Lewis; Mariana Justino de Almeida; Judith Straimer; Philipp P Henrich; Eugene Palatulan; David J Johnson; Olivia Coburn-Flynn; Cecilia Sanchez; Adele M Lehane; Michael Lanzer; David A Fidock
Journal:  Mol Microbiol       Date:  2015-05-20       Impact factor: 3.501

3.  Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).

Authors:  Paul S Callaghan; Matthew R Hassett; Paul D Roepe
Journal:  Biochemistry       Date:  2015-08-06       Impact factor: 3.162

Review 4.  Recent highlights in antimalarial drug resistance and chemotherapy research.

Authors:  David A Fidock; Richard T Eastman; Stephen A Ward; Steven R Meshnick
Journal:  Trends Parasitol       Date:  2008-10-18

5.  Expanding the Antimalarial Drug Arsenal-Now, But How?

Authors:  Brian T Grimberg; Rajeev K Mehlotra
Journal:  Pharmaceuticals (Basel)       Date:  2011-05-01

6.  Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.

Authors:  Nobuyuki Takahashi; Kazuyuki Tanabe; Takahiro Tsukahara; Mawuli Dzodzomenyo; Lek Dysoley; Boualam Khamlome; Jetsumon Sattabongkot; Masatoshi Nakamura; Miki Sakurai; Jun Kobayashi; Akira Kaneko; Hiroyoshi Endo; Francis Hombhanje; Takafumi Tsuboi; Toshihiro Mita
Journal:  Malar J       Date:  2012-03-28       Impact factor: 2.979

7.  Metabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolism.

Authors:  Ian A Lewis; Mark Wacker; Kellen L Olszewski; Simon A Cobbold; Katelynn S Baska; Asako Tan; Michael T Ferdig; Manuel Llinás
Journal:  PLoS Genet       Date:  2014-01-02       Impact factor: 5.917

8.  High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia.

Authors:  Lemu Golassa; Nizar Enweji; Berhanu Erko; Abraham Aseffa; Göte Swedberg
Journal:  Malar J       Date:  2014-03-27       Impact factor: 2.979

9.  Combinatorial Genetic Modeling of pfcrt-Mediated Drug Resistance Evolution in Plasmodium falciparum.

Authors:  Stanislaw J Gabryszewski; Charin Modchang; Lise Musset; Thanat Chookajorn; David A Fidock
Journal:  Mol Biol Evol       Date:  2016-02-22       Impact factor: 16.240

10.  Molecular identification and anti-malarial drug resistance profile of Plasmodium falciparum from patients attending Kisoro Hospital, southwestern Uganda.

Authors:  Godfrey Manirakiza; Kennedy Kassaza; Ivan Mugisha Taremwa; Joel Bazira; Fredrick Byarugaba
Journal:  Malar J       Date:  2022-01-15       Impact factor: 2.979
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.